Yhn HealthMental Health first seen 7 d ago, last 2 h ago, peak #1
One-Shot CRISPR Therapies Targeting PCSK9 Gain Attention
Original: In-Vivo CRISPR/Base-Editing "One-Shot" Therapies Targeting PCSK9
A newly published review in Current Atherosclerosis Reports examines in-vivo CRISPR and base-editing therapies that target PCSK9, a gene that regulates cholesterol levels. The approach would require only a single treatment to permanently lower LDL cholesterol, potentially replacing daily statins for some patients. Early trials of similar one-time gene-editing cholesterol therapies have generated excitement about the future of cardiovascular prevention.
Why now: Fresh publication of a scientific review on a promising single-dose gene-editing treatment for high cholesterol
PCSK9CRISPRCurrent Atherosclerosis ReportsSpringer
Rank over time, top of the chart is #1. 121 snapshots from 6 d ago to 2 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3255814